These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8643484)

  • 81. Identification of in vivo phosphorylation sites of SET, a nuclear phosphoprotein encoded by the translocation breakpoint in acute undifferentiated leukemia.
    Adachi Y; Pavlakis GN; Copeland TD
    FEBS Lett; 1994 Mar; 340(3):231-5. PubMed ID: 8131851
    [TBL] [Abstract][Full Text] [Related]  

  • 82. CXCR4 Mediates Enhanced Cell Migration in
    Fertal SA; Zaidi SK; Stein JL; Stein GS; Heath JL
    Front Oncol; 2021; 11():708915. PubMed ID: 35070954
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Diagnostic challenge in a case of ambiguous lineage acute leukemia with PICALM::MLLT10 rearrangement.
    Quessada J; Petit A; Saultier P; Fenwarth L; Marceau-Renaut A; Arnoux I; Payet-Bornet D; Michel G; Lafage M; Loosveld M
    Pediatr Blood Cancer; 2023 Nov; 70(11):e30573. PubMed ID: 37439579
    [No Abstract]   [Full Text] [Related]  

  • 84. Up a lymphoid blind alley: Does CALM/AF10 disturb Ikaros during leukemogenesis?
    Greif PA; Bohlander SK
    World J Biol Chem; 2011 Jun; 2(6):115-8. PubMed ID: 21765976
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Alzheimer disease: Alzheimer disease risk factor CALM modulates tau turnover.
    Wood H
    Nat Rev Neurol; 2014 Nov; 10(11):610. PubMed ID: 25311586
    [No Abstract]   [Full Text] [Related]  

  • 86. Picalm, a novel regulator of GLUT4-trafficking in adipose tissue.
    Gaugel J; Haacke N; Sehgal R; Jähnert M; Jonas W; Hoffmann A; Blüher M; Ghosh A; Noé F; Wolfrum C; Tan J; Schürmann A; Fazakerley DJ; Vogel H
    Mol Metab; 2024 Oct; 88():102014. PubMed ID: 39182843
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Differential effects of ascorbic acid on monocytic cell morphology and protein modification: Shifting from pro-oxidative to antioxidant properties.
    Prasad A; Rathi D; Sedlářová M; Manoharan RR; Průdková E; Pospíšil P
    Biochem Biophys Rep; 2024 Mar; 37():101622. PubMed ID: 38234371
    [TBL] [Abstract][Full Text] [Related]  

  • 88. PICALM as a Novel Prognostic Biomarker and Its Correlation with Immune Infiltration in Breast Cancer.
    A N; Lyu P; Yu Y; Liu M; Cheng S; Chen M; Liu Y; Cao X
    Appl Biochem Biotechnol; 2024 Jan; ():. PubMed ID: 38175412
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
    Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
    Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Real-time heterogeneity of supramolecular assembly of amyloid precursor protein is modulated by an endocytic risk factor PICALM.
    Belapurkar V; Mahadeva Swamy HS; Singh N; Kedia S; Setty SRG; Jose M; Nair D
    Cell Mol Life Sci; 2023 Sep; 80(10):295. PubMed ID: 37726569
    [TBL] [Abstract][Full Text] [Related]  

  • 91. MOZ/ENL complex is a recruiting factor of leukemic AF10 fusion proteins.
    Komata Y; Kanai A; Maeda T; Inaba T; Yokoyama A
    Nat Commun; 2023 Apr; 14(1):1979. PubMed ID: 37031220
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Eukaryotic Clathrin Adapter Protein and Mediator of Cholesterol Homeostasis, PICALM, Affects Trafficking to the Chlamydial Inclusion.
    Jorgenson LM; Knight L; Widner RE; Rucks EA
    Mol Cell Biol; 2023 Feb; 43(2):1-13. PubMed ID: 36779337
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 94. PICALM and Alzheimer's Disease: An Update and Perspectives.
    Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway.
    Zhang X; Liu T; Huang J; He J
    Cancer Cell Int; 2022 May; 22(1):178. PubMed ID: 35501863
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report.
    Kudo K; Kubota Y; Toki T; Kanezaki R; Kobayashi A; Sato T; Kamio T; Sasaki S; Shiba N; Tomizawa D; Adachi S; Yoshida K; Ogawa S; Seki M; Takita J; Ito E; Terui K
    Blood Adv; 2022 May; 6(10):3162-3166. PubMed ID: 35139176
    [No Abstract]   [Full Text] [Related]  

  • 97. The role of Alzheimer's disease risk genes in endolysosomal pathways.
    Szabo MP; Mishra S; Knupp A; Young JE
    Neurobiol Dis; 2022 Jan; 162():105576. PubMed ID: 34871734
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18.
    Maher M; Diesch J; Le Pannérer MM; Cabezón M; Mallo M; Vergara S; Méndez López A; Mesa Tudel A; Solé F; Sorigue M; Zamora L; Granada I; Buschbeck M
    Sci Rep; 2021 Oct; 11(1):21145. PubMed ID: 34707142
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genetics and Diagnostic Approach to Lymphoblastic Leukemia/Lymphoma.
    Afkhami M; Ally F; Pullarkat V; Pillai RK
    Cancer Treat Res; 2021; 181():17-43. PubMed ID: 34626353
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Synaptic tau: A pathological or physiological phenomenon?
    Robbins M; Clayton E; Kaminski Schierle GS
    Acta Neuropathol Commun; 2021 Sep; 9(1):149. PubMed ID: 34503576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.